WallStreetZenWallStreetZen

NASDAQ: APTO
Aptose Biosciences Inc Stock Ownership - Who owns Aptose Biosciences?

Insider buying vs selling

Have Aptose Biosciences Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Bernd R. SeizingerDirector2023-09-2217,000$3.14
$53.38kBuy

1 of 1

APTO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APTO insiders and whales buy or sell their stock.

APTO Shareholders

What type of owners hold Aptose Biosciences Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Donald R. Wilson Jr.54.54%8,895,238$7.74MInsider
Drw Securities LLC3.63%592,829$515.76kInstitution
William G. Rice3.15%513,252$446.53kInsider
Erich Platzer3.10%505,000$439.35kInsider
Gregory K. Chow1.43%232,846$202.58kInsider
Sigma Planning Corp1.14%186,417$162.18kInstitution
Fletcher Payne0.74%120,000$104.40kInsider
Jotin Marango0.71%116,219$101.11kInsider
Rafael Bejar0.67%110,000$95.70kInsider
Philippe Ledru0.62%100,500$87.44kInsider

1 of 3

APTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APTO6.21%65.32%Net Buying
PPBT0.97%0.00%
EDSA1.26%98.74%Net BuyingNet Buying
BRTX0.38%99.62%Net BuyingNet Buying
XTLB0.05%20.78%

Aptose Biosciences Stock Ownership FAQ

Who owns Aptose Biosciences?

Aptose Biosciences (NASDAQ: APTO) is owned by 6.21% institutional shareholders, 65.32% Aptose Biosciences insiders, and 28.47% retail investors. Donald R. Wilson Jr. is the largest individual Aptose Biosciences shareholder, owning 8.90M shares representing 54.54% of the company. Donald R. Wilson Jr.'s Aptose Biosciences shares are currently valued at $7.45M.

If you're new to stock investing, here's how to buy Aptose Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.